Escitalopram Oxalate
Product Images NDC 67046-174

6 FDA label images from Contract Pharmacy Services-pa · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Escitalopram Oxalate (NDC 67046-174). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Contract Pharmacy Services-pa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (31e1e1b4 0738 446c 8861 Af5c49d08b54 01)

1 (31e1e1b4 0738 446c 8861 Af5c49d08b54 01)
A data table titled 'Treatment-Emergent Adverse Reactions observed with a frequency of ≥2% and greater than placebo for Major Depressive Disorder.' The table compares adverse reactions between escitalopram oxalate (N=715) and placebo (N=592), listing disorders such as autonomic nervous system, central and peripheral nervous system, gastrointestinal, general, psychiatric, respiratory, and urogenital, with percentage incidence for each group. Footnotes clarify denominators used for males and females in specific adverse reactions.*
FDA Label Image

2 (31e1e1b4 0738 446c 8861 Af5c49d08b54 02)

2 (31e1e1b4 0738 446c 8861 Af5c49d08b54 02)
Table showing treatment-emergent adverse reactions for escitalopram oxalate versus placebo in generalized anxiety disorder. Categories include autonomic nervous, central and peripheral nervous, gastrointestinal, general, musculoskeletal, psychiatric, respiratory, and urogenital disorders, with corresponding percentages of occurrence in each group.*
FDA Label Image

1 (31e1e1b4 0738 446c 8861 Af5c49d08b54 03)

1 (31e1e1b4 0738 446c 8861 Af5c49d08b54 03)
Chemical structure diagram of escitalopram oxalate, depicting the molecular arrangement including aromatic rings, fluorine, nitrile groups, and associated atoms.*
FDA Label Image

Logo (31e1e1b4 0738 446c 8861 Af5c49d08b54 04)

FDA Label Image

1 (31e1e1b4 0738 446c 8861 Af5c49d08b54 05)

FDA Label Image

Dahej (31e1e1b4 0738 446c 8861 Af5c49d08b54 09)

Dahej (31e1e1b4 0738 446c 8861 Af5c49d08b54 09)
Label for escitalopram oxalate 20 mg tablets, bottle of 30. The label states prescription only with lot number 4DD4C066 and expiration date 06/15/18. It includes storage instructions and notes each film-coated tablet contains escitalopram oxalate USP equivalent to 20 mg escitalopram. Packaged by Contract Pharmacy Services-PA with NDC 67046-174-30.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.